Innoviva (INVA) Interest Expenses (2010 - 2026)
Innoviva (INVA) reported Interest Expenses of $5.47 million for Q2 2026, up 17.3% from $4.66 million a year earlier and up 0.6% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Interest Expenses (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Innoviva's Interest Expenses came in at $18.23 million, down 8.5% year-over-year; for FY2025, it came in at $16.7 million, down 24.8% from FY2024.
- Interest Expenses has a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
- By year, Interest Expenses came in at $22.21 million in FY2024 (+15.9%), $19.16 million in FY2023 (+21.3%), $15.79 million in FY2022 (-17.2%) and $19.07 million in FY2021 (+4.0%).
- The Q2 2026 figure ranks as the highest quarterly Interest Expenses since Q3 2024.
- Year over year, Interest Expenses gained in two of the last six quarters, with an average decline of 11.3%.
- The high point for year-over-year Interest Expenses in five years was Q1 2023 (growth of 47.1%); the low point was Q1 2022 (a decline of 35.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.44 million (Q1 2026), $3.31 million (Q4 2025) and $4.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Innoviva | 1.54 Bn | -750.13 Mn | 90.62 Mn | 5.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.47 Mn |
| Mar 31, 2026 | 5.44 Mn |
| Dec 31, 2025 | 3.31 Mn |
| Sep 30, 2025 | 4.02 Mn |
| Jun 30, 2025 | 4.66 Mn |
| Mar 31, 2025 | 4.71 Mn |
| Dec 31, 2024 | 4.75 Mn |
| Sep 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 5.80 Mn |
| Mar 31, 2024 | 5.85 Mn |
| Sep 30, 2023 | 4.40 Mn |
| Jun 30, 2023 | 4.38 Mn |
| Mar 31, 2023 | 4.43 Mn |
| Sep 30, 2022 | 5.10 Mn |
| Jun 30, 2022 | 3.66 Mn |
| Mar 31, 2022 | 3.01 Mn |
| Dec 31, 2021 | 4.84 Mn |
| Sep 30, 2021 | 4.79 Mn |
| Jun 30, 2021 | 4.75 Mn |
| Mar 31, 2021 | 4.69 Mn |
API Access
Innoviva Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();